Research Alliance Corp II (RACB)
$10.11
$0.00 (0.00%)As on 15-Dec-2022 09:30EDT
Market cap
$194 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
168.4
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-241.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0
-
Face value
--
-
Shares outstanding
15,449,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Research Alliance Corp II (RACB)
| 3.4 | 0.7 | 2.9 | 2.2 | -- | -- | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Research Alliance Corp II (RACB)
|
10.1 | 193.9 | 0.0 | 0.1 | -- | 0 | 168.4 | 1.3 |
| 10.1 | 505.8 | -0.5 | 18.7 | -4,040.4 | 4.9 | 27.3 | 1.3 | |
| 10.1 | 433.4 | 0.0 | 7.1 | -- | -- | 71.8 | 1.3 | |
| 10.0 | 1,726.7 | 0.0 | 43.3 | -- | -- | 9.3 | 1.3 | |
| 10.1 | 434.3 | 0.0 | 9.6 | -- | -- | 45.8 | 1.3 | |
| 25.1 | 445.4 | 0.0 | 13.3 | -- | -- | 71.7 | 1.1 | |
| 10.0 | 580.1 | 0.0 | 6,291,149.5 | -- | -- | 28.7 | 1.1 | |
| 10.1 | 435.1 | 0.0 | 12.5 | -- | -- | 34.8 | 1.3 | |
| 10.0 | 581.1 | 0.0 | 9.5 | -- | -- | 71.6 | 1.3 | |
| 10.1 | 443.1 | 0.0 | -4.4 | -- | -- | 91.5 | 1.3 |
Shareholding Pattern
View DetailsAbout Research Alliance Corp II (RACB)
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It... identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada. Read more
-
Co-Founder, Chairman & CEO
Dr. Peter Kolchinsky Ph.D.
-
Co-Founder, Chairman & CEO
Dr. Peter Kolchinsky Ph.D.
-
Headquarters
Las Vegas, NV
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Research Alliance Corp II (RACB)
What is the current share price of Research Alliance Corp II (RACB) Today?
The share price of Research Alliance Corp II (RACB) is $10.11 (NASDAQ) as of 15-Dec-2022 09:30 EDT. Research Alliance Corp II (RACB) has given a return of 2.17% in the last 1 years.
What is the current PB & PE ratio of Research Alliance Corp II (RACB)?
The P/E ratio of Research Alliance Corp II (RACB) is 168.42 times as on 13-Jan-2023.
The P/B ratio of Research Alliance Corp II (RACB) is 1.33 times as on 13-Jan-2023, a 1 premium to its peers’ median range of 1.32 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-85.70 |
-9.43 |
2020 |
-- |
-- |
2021 |
-85.70 |
-9.43 |
2020 |
-- |
-- |
What is the 52 Week High and Low of Research Alliance Corp II (RACB)?
The 52-week high and low of Research Alliance Corp II (RACB) are Rs -- and Rs -- as of 07-Sep-2026.
What is the market cap of Research Alliance Corp II (RACB)?
Research Alliance Corp II (RACB) has a market capitalisation of $ 194 Mln as on 13-Jan-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Research Alliance Corp II (RACB)?
Before investing in Research Alliance Corp II (RACB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.